Join our community of smart investors

Buying biotech and finding the next Tesla

Douglas Brodie tells Kate Beioley why he is buying early-stage biotech
Buying biotech and finding the next Tesla

Small-cap biotech stocks are among the most exciting opportunities in the world, or so says Douglas Brodie, manager of Edinburgh Worldwide Investment Trust (EWI) and Baillie Gifford Global Discovery fund (GB0006059116).

Biotech is the area Mr Brodie is most positive about and around 20 per cent of Edinburgh Worldwide's assets are in this area. This includes companies that are not yet profitable and whose fortunes hinge on the outcome of single drugs - around one-third of the trust's assets are in pre-profit companies.

Mr Brodie argues that despite the apparently high-risk nature of biotech investing scientific advances have made it easier to spot the winners.

To continue reading...
OR
Register for free
Read 3 articles for free each month
* Excl. premium articles
Have an account? Sign in